BEIJING, Oct. 8, 2018 /PRNewswire/ Yisheng Biopharma Co., Ltd. (“Yisheng Biopharma”), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immune modulator biotherapeutics and vaccines, today announced...
A showcase to highlight anti-cancer efficacy of systemic and intratumoral treatment of YS-ON-001 BEIJING, March 28, 2019 /PRNewswire/ Yisheng Biopharma Co., Ltd. (“Yisheng Biopharma”), a biopharmaceutical company focusing on...